The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM)
Clinical trial NCT01449019 · COMPLETED
Trial details
- NCT number
- NCT01449019
- Sponsor
- Ludwig-Maximilians - University of Munich
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2007-08-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.